The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

Increasingly, telehealth platforms are positioning blockbuster weight-loss shots not as medicines to treat obesity or diabetes but as cosmetic elixirs for anyone who wants to lose a few pounds.

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...